breast cancer Archive — Page 3 of 23

Authors on the study included, from left, Jennifer Pietenpol, PhD, Melinda Sanders, MD, Brian Lehmann, PhD, Vandana Abramson, MD, and Yu Shyr, PhD. (photo by Donn Jones)
December 15, 2023

Clinical trial shows efficacy for atezolizumab combined with carboplatin

By Tom Wilemon
November 30, 2023

Emerging Technology & Talent

By Tom Wilemon
November 30, 2023

3D Ingenuity

By Tom Wilemon
November 30, 2023

Destination Care

By Tom Wilemon
November 30, 2023

Research that’s Practice Changing Paradigm Shifting & Policy Creating

By Tom Wilemon
The study team included, from left, Paula Gonzalez-Ericsson, MD, Xiaopeng Sun, Justin Balko, PharmD, PhD, and Brandie Taylor, MS. (photo by Donn Jones)
October 4, 2023

Vulnerability found in immunotherapy-resistant triple-negative breast cancer

Vanderbilt researchers have discovered a druggable target on natural killer cells that could potentially trigger a therapeutic response in patients with immunotherapy-resistant, triple-negative breast cancer.

By Tom Wilemon